← Russell 3000 cross-section

A AGILENT TECHNOLOGIES, INC.

Trailing twelve months to 2026-04-30 · as filed 2026-06-01, not restated
Healthcare

Scale

Market cap
$44.6bn
Revenue TTM
$7.2bn
Net income TTM
$1.4bn
Free cash flow
$1.1bn
Composite score
50.8
Sector rank
#261

Valuation

P / E
31.6
EV / EBITDA
25.2
EV / sales
6.4
FCF yield
2.44%
Earnings yield vs 10-yr
-1.56pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
19.6%
EBITDA margin
25.3%
ROE
19.9%
ROIC
17.9%
Revenue growth
9.1%

Insider activity, last 90 days

Net open-market
$-0.22m
Buyers
0
Sellers
1

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

While tariffs remain dynamic, we have mitigated the adverse impact related to our cost of revenue during the three and six months ended April 30, 2026 through our continued mitigation strategies such as supply chain optimization, targeted pricing actions, and other cost-efficiency initiatives to protect margins and sustain long-term growth. Actual Results Net revenue of $1,835 million and $3,633 million for the three and six months ended April 30, 2026 increased 10 percent and 8 percent, respectively, when compared to the same periods last year. …AGILENT TECHNOLOGIES, INC., 10-Q, period ended 2026-04-30, filed 2026-06-01

Read the full passage →